Drug Repositioning: Exploring New Therapeutic Uses for Approved Medicines
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (36s)
DOI: 10.25258/ijddt.16.36s.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Lavanya B und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Drug discovery is a complex, time-intensive and costly process with high attrition rates in clinical development. Drug repositioning (also known as drug repurposing or reprofiling) has emerged as an efficient alternative strategy that identifies new therapeutic indications for existing approved drugs. By leveraging established safety, pharmacokinetic, and toxicity data, repositioning reduces development time, cost, and risk compared to de novo drug discovery. This review aims to provide a comprehensive overview of drug repositioning strategies, highlight recent successful examples, discuss underlying molecular mechanisms, and examine current challenges and regulatory considerations in modern therapeutics. Drug repositioning has demonstrated significant success across oncology, infectious diseases, neurology, and cardiovascular medicine. Notable examples include sildenafil (PDE-5 inhibition), thalidomide (immunomodulation and anti-angiogenesis), remdesivir (RNA-dependent RNA polymerase inhibition), aspirin (COX inhibition and antiplatelet activity), and minoxidil (vasodilatory and follicular stimulation effects). Advances in computational biology, network pharmacology, real-world evidence analysis Drug repositioning represents a cost-effective and translationally viable strategy to address unmet medical needs. Integration of multiomics data, computational tools, and precision medicine approaches will further enhance the success rate of repositioned therapeutics. Continued regulatory refinement and collaborative research frameworks are essential to maximize its clinical impact.
Zitieren
APA
B, L., D, S., D, B., A, K., L, D., K, T., & R, S. (2026). Drug Repositioning: Exploring New Therapeutic Uses for Approved Medicines. International Journal of Drug Delivery Technology, 16(36s). https://doi.org/10.25258/ijddt.16.36s.38
Vancouver
B L, D S, D B, A K, L D, K T, et al. Drug Repositioning: Exploring New Therapeutic Uses for Approved Medicines. International Journal of Drug Delivery Technology. 2026;16(36s). doi:10.25258/ijddt.16.36s.38
BibTeX
@article{B2026,
author = {B, Lavanya and D, Saravanan and D, Bharathi and A, Kavidha and L, Diana and K, Thanrasu and R, Srinivasan},
title = {Drug Repositioning: Exploring New Therapeutic Uses for Approved Medicines},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {36s},
doi = {10.25258/ijddt.16.36s.38}
}
EUVIMED